4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000478
Chief Executive Officer sold 9,952 shares at an average $31.01 ($308,637)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −4,634 | $30.74 | $142,449 | 3,720,366 | D: show line 1 in the form |
| Anzalone Christopher Richard Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −5,318 | $31.25 | $166,188 | 3,715,048 | D: show line 2 in the form |
| Open-market sales · 9,952 sh · avg $31.01 · $308,637 | |||||||
Loading xslF345X05/wk-form4_1704407090.xml…